GlassScriptPhysician profile
Monika Datt
NPI 1578716262
$4,764.29
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $1,461 · 2021: $1,416 · 2022: $907.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,443.93 | 2019-2022 | |
| Amarin Pharma, INC. | $544.43 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $485.36 | 2019-2022 | |
| Lilly USA, LLC | $434.02 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.32 | 2021-2022 | |
| Amgen INC. | $261.00 | 2019-2022 | |
| Abbvie INC. | $209.23 | 2020-2022 | |
| Radius Health, INC. | $202.50 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $202.45 | 2019-2022 | |
| Dexcom, INC. | $190.52 | 2019-2022 | |
| Abbott Laboratories | $93.03 | 2021 | |
| Janssen Pharmaceuticals, INC | $72.94 | 2019-2020 | |
| Ibsa Pharma INC. | $57.04 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.91 | 2021 | |
| Genentech USA, INC. | $44.54 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $43.13 | 2019 | |
| Insulet Corporation | $34.95 | 2019 | |
| Medtronic, INC. | $34.01 | 2021 | |
| Eusa Pharma (US) LLC | $22.91 | 2022 | |
| Recordati_rare_diseases_inc. | $22.91 | 2022 | |
| Mannkind Corporation | $17.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monika Datt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.